Themis Medicare cash flow

·Pharma & HealthChart ›
Latest FY26
Cash from operations
−₹3.3cr₹34.7 cr in FY25
Capital spending
₹4.9cr−68.4% on FY25
Free cash flow
−₹8.1cr₹19.3 cr in FY25
Cash from financing
₹3.8cr−₹25.9 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—10.39.912.210.5
—0.00.0−0.00.0
—0.08.50.08.0
—0.0−1.10.00.0
—0.0−0.4−2.4−4.8
—−0.00.0−0.1−0.1
—0.00.00.0−0.0
—0.00.00.00.0
—0.0−0.10.00.0
—0.00.00.0−0.0
Changes in working capital
—3.2−13.7−1.6−8.1
—−1.00.8−32.9−44.5
—0.0−1.40.01.5
—−0.20.05.80.0
—−6.8−3.20.0−5.4
—1.73.1−3.0−0.1
—−0.64.17.28.2
—1.50.02.87.7
—0.04.10.2−0.1
—0.00.20.00.0
—−0.40.00.00.0
—0.70.00.60.5
—0.00.70.00.0
Cash from operating activities
37.8−12.133.734.658.9
—8.311.7−11.2−26.6
—−3.845.523.432.2
—−8.90.00.00.0
—−2.00.00.00.0
—6.410.89.016.2
—−3.334.714.516.1
Cash from investing activities
—4.915.418.428.7
—0.41.70.00.0
—0.00.00.00.0
—1.70.41.64.2
—0.31.10.80.5
—−2.5−12.2−15.9−24.0
Cash from financing activities
—0.20.00.00.1
—17.10.05.54.6
—0.012.81.7−8.8
—0.00.00.40.8
—8.98.50.08.0
—4.64.64.64.6
—3.8−25.9−1.10.1
—−2.0−3.4−2.6−7.7
—−2.0−3.4−2.6−7.7
———9.912.5
Reference items
−41.90.449.051.567.5
−12.6%0.1%12.1%13.5%19.0%
−8.1−8.119.3−4.0−12.7
—0.1−2.0——
−₹0.88−₹0.88₹2.09−₹0.43−₹1.37
—−2.86×1.16×0.33×0.28×
—6.410.89.016.2
—8.98.5—8.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

THEMISMED₹98.44

Themis Medicare Limited

· Pharma & Health
₹ CrorePeersLINCOLNBAJAJHCARESIGACHIWANBURYAMRUTANJANAHCLANUHPHRMcap ₹907 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation10.512.29.910.3—
+ Impairment Loss / (Reversal)0.0-0.00.00.0—
+ Finance Costs8.00.08.50.0—
+ Interest Income0.00.0-1.10.0—
+ Dividend Income-4.8-2.4-0.40.0—
+ Fair Value (Gains) / Losses-0.1-0.10.0-0.0—
+ Unrealised FX (Gain) / Loss-0.00.00.00.0—
+ Other Non-cash Items0.00.00.00.0—
+ Other — Cash Effects are Investing / Financing0.00.0-0.10.0—
+ Other Reconciling Items-0.00.00.00.0—
Changes in Working Capital
+ Inventories-8.1-1.6-13.73.2—
+ Trade Receivables — Current-44.5-32.90.8-1.0—
+ Other Financial Assets — Non-current1.50.0-1.40.0—
+ Other Current Assets0.05.80.0-0.2—
+ Other Non-current Assets-5.40.0-3.2-6.8—
+ Other Bank Balances-0.1-3.03.11.7—
+ Trade Payables — Current8.27.24.1-0.6—
+ Other Financial Liabilities — Current7.72.80.01.5—
+ Other Financial Liabilities — Non-current-0.10.24.10.0—
+ Other Current Liabilities0.00.00.20.0—
+ Other Non-current Liabilities0.00.00.0-0.4—
+ Provisions — Current0.50.60.00.7—
+ Provisions — Non-current0.00.00.70.0—
Cash from Operating Activities
Profit Before Tax (per I/S)58.934.633.7-12.137.8
+ Total Adjustments (incl. Working Capital)-26.6-11.211.78.3—
Cash from Operations (pre-tax)32.223.445.5-3.8—
+ Interest Paid — Operating0.00.00.0-8.9—
+ Dividends Received — Operating0.00.00.0-2.0—
+ Income Taxes Paid16.29.010.86.4—
Cash from Operating Activities16.114.534.7-3.3—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)28.718.415.44.9—
+ Disp of Fixed Assets0.00.01.70.4—
+ Disp of Investment Property0.00.00.00.0—
+ Dividends Received — Investing4.21.60.41.7—
+ Interest Received — Investing0.50.81.10.3—
Cash from Investing Activities-24.0-15.9-12.2-2.5—
Cash from Financing Activities
+ Proceeds from Issue of Shares0.10.00.00.2—
+ Proceeds from Borrowings4.65.50.017.1—
+ Repayment of Borrowings-8.81.712.80.0—
+ Payment of Lease Liabilities0.80.40.00.0—
+ Interest Paid8.00.08.58.9—
+ Dividends Paid4.64.64.64.6—
Cash from Financing Activities0.1-1.1-25.93.8—
Net Changes in Cash (pre-FX)-7.7-2.6-3.4-2.0—
Net Changes in Cash-7.7-2.6-3.4-2.0—
Closing Cash12.59.9———
Reference Items
EBITDA67.551.549.00.4-41.9
EBITDA Margin %19.0413.4912.100.11-12.65
Free Cash Flow (CFO − Capex)-12.7-4.019.3-8.1-8.1
Free Cash Flow to Equity——-2.00.1—
Free Cash Flow per Basic Share-1.37-0.432.09-0.88-0.88
Cash Flow to Net Income0.280.331.16-2.86—
Cash Paid for Taxes16.29.010.86.4—
Cash Paid for Interest8.0—8.58.9—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.